Related Experiment Video

Updated: Jul 15, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in

Bohanec Grabar Petra1, Jazbec Janez, Dolzan Vita

  • 1Institute of Biochemistry, University of Ljubljana, Ljubljana, Slovenia.

Leukemia & Lymphoma
|April 25, 2007
PubMed

Insights

Genetic variations in folate metabolism may influence childhood acute lymphoblastic leukemia (ALL) risk. Certain gene combinations, particularly those reducing methylation capacity, appear to offer protection against developing ALL.

Area of Science:

  • Genetics
  • Oncology
  • Biochemistry

Background:

  • Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer.
  • Genetic polymorphisms in the folate pathway are implicated in DNA synthesis and methylation, potentially affecting cancer risk.
  • Understanding these genetic factors is crucial for identifying susceptibility to childhood ALL.

Purpose of the Study:

  • To investigate the influence of common genetic polymorphisms in the folate metabolic pathway on the risk of childhood ALL.
  • To analyze specific gene variants in MTHFR, TS, MS, and MTRR in children with ALL and healthy controls.
  • To explore potential gene-gene interactions affecting ALL susceptibility.

Main Methods:

  • Case-control study involving 68 children with ALL and 258 healthy controls.
  • Genotyping analysis of common polymorphisms in 5,10-methylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS), methionine synthase (MS), and methionine synthase reductase (MTRR).
  • Statistical analysis to compare genotype frequencies and calculate odds ratios (OR) and confidence intervals (CI).

Main Results:

  • No significant differences in the frequencies of individual polymorphisms were found between ALL patients and controls.
  • Combined MTHFR 677CT/TT and MS 2756AG/GG genotypes showed a non-significant trend towards reduced ALL risk (OR 2.24).
  • A significant reduction in ALL risk was observed with combined MTHFR 677CT/TT, MS 2756AG/GG, and MTRR 66AG/GG genotypes (OR 0.312, P=0.032).

Conclusions:

  • Individual folate pathway polymorphisms do not appear to significantly alter the risk for childhood ALL.
  • Gene-gene interactions within the folate pathway, specifically those decreasing methylation capacity, may have a protective effect against childhood ALL.
  • Further research into gene-gene interactions is warranted to understand their role in ALL pathogenesis.

More Related Videos

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...